Priming of cancer-immunity cycle by alleviating hypoxia-induced ferroptosis resistance and immunosuppression
{{output}}
Stimulating a robust cancer-immunity cycle (CIC) holds promising potential for eliciting potent and enduring immune responses for cancer immunotherapy. However, designing a therapeutic nanomaterial capable of both enhancing tumor immunogenicity and mitigating ... ...
